News & Media

TDM ploughs $50m into anti-cancer biotech QBiotics
Financial Review (PDF)
16 Mar 2021
Read More
QBiotics joins TDM Growth Partners to accelerate drug development timelines
BioSpectrum Asia
15 Mar 2021
Read More
Virbac Teams With QBiotics On Cancer Product
Today's Veterinary Business
30 Nov 2020
Read More
New Drug to Treat Some Mast Cell Tumors in Dogs
Steve Dale Pet World
22 Nov 2020
Read More
FDA approval for QBiotics' canine cancer treatment
Biotech Dispatch
19 Nov 2020
Read More
FDA Approves QBiotics’ Veterinary Anti-Cancer Treatment Stelfonta
Pet Insight
19 Nov 2020
Read More
QBiotics' STELFONTA Receives FDA Approval for Canine Mast cell Tumours
BioSpace.com
18 Nov 2020
Read More
FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs
U.S. Food and Drug Administration
16 Nov 2020
Read More
New canine cancer treatment available
Vet Practice Magazine
22 Jun 2020
Read More
Promising New Cancer Treatment for Dogs with Mast Cell Tumours
Australian Dog Lover
17 Jun 2020
Read More
QBiotics commercialises first tigilanol tiglate pharmaceutical product
Biotech Dispatch
30 Apr 2020
Read More
Dr Boreham’s Crucible: Why unlisted QBiotics has a good chance of cracking the cancer market
Stockhead.com
15 Mar 2020
Read More

Page 2 of 3